72 related articles for article (PubMed ID: 23879077)
1. Screening for BRCA1 large genomic rearrangements in female Egyptian hereditary breast cancer patients.
Hagag E; Shwaireb M; Coffa J; El Wakil A
East Mediterr Health J; 2013 Mar; 19(3):255-62. PubMed ID: 23879077
[TBL] [Abstract][Full Text] [Related]
2. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
3. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
[TBL] [Abstract][Full Text] [Related]
4. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
[TBL] [Abstract][Full Text] [Related]
5. The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer.
Kwong A; Chen J; Shin VY; Ho JC; Law FB; Au CH; Chan TL; Ma ES; Ford JM
Cancer Genet; 2015 Sep; 208(9):448-54. PubMed ID: 26271414
[TBL] [Abstract][Full Text] [Related]
6. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.
Sluiter MD; van Rensburg EJ
Breast Cancer Res Treat; 2011 Jan; 125(2):325-49. PubMed ID: 20232141
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer.
Sharifah NA; Nurismah MI; Lee HC; Aisyah AN; Clarence-Ko CH; Naqiyah I; Rohaizak M; Fuad I; A Jamal AR; Zarina AL; Nor Aina E; Normayah K; Nor Hisham A
Cancer Epidemiol; 2010 Aug; 34(4):442-7. PubMed ID: 20451485
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of BRCA1 Large Genomic Rearrangements in Group of Egyptian Female Breast Cancer Patients Using MLPA.
Eid OM; El Ghoroury EA; Eid MM; Mahrous RM; Abdelhamid MI; Aboafya ZI; Abdel Ghaffar EA; Abdelrahman AH
Gulf J Oncolog; 2017 Sep; 1(25):64-69. PubMed ID: 29019333
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
10. Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients.
Aktas D; Gultekin M; Kabacam S; Alikasifoglu M; Turan AT; Tulunay G; Kose MF; Ortac F; Yüce K; Tunçbilek E; Ayhan A
Gynecol Oncol; 2010 Oct; 119(1):131-5. PubMed ID: 20638108
[TBL] [Abstract][Full Text] [Related]
11. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families.
Woodward AM; Davis TA; Silva AG; Kirk JA; Leary JA;
J Med Genet; 2005 May; 42(5):e31. PubMed ID: 15863663
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
Gutiérrez-Enríquez S; de la Hoya M; Martínez-Bouzas C; Sanchez de Abajo A; Ramón y Cajal T; Llort G; Blanco I; Beristain E; Díaz-Rubio E; Alonso C; Tejada MI; Caldés T; Diez O
Breast Cancer Res Treat; 2007 May; 103(1):103-7. PubMed ID: 17063271
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer.
Su L; Zhang J; Meng H; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Clin Genet; 2018 Jul; 94(1):165-169. PubMed ID: 29582426
[TBL] [Abstract][Full Text] [Related]
15. Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.
Iau PT; Marafie M; Ali A; Sng JH; Macmillan RD; Pinder S; Denley HE; Ellis IO; Wenzyck P; Scott N; Cross G; Blamey RW
Breast Cancer Res Treat; 2004 May; 85(1):81-8. PubMed ID: 15039599
[TBL] [Abstract][Full Text] [Related]
16. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
[TBL] [Abstract][Full Text] [Related]
17. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.
Hofmann W; Görgens H; John A; Horn D; Hüttner C; Arnold N; Scherneck S; Schackert HK
Hum Mutat; 2003 Jul; 22(1):103-4. PubMed ID: 12815601
[TBL] [Abstract][Full Text] [Related]
18. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
[TBL] [Abstract][Full Text] [Related]
19. Using MLPA for large genomic rearrangements detection in breast cancer predisposition genes.
Negură L; Carasevici E; Artenie V; Negură A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1182-90. PubMed ID: 20191896
[TBL] [Abstract][Full Text] [Related]
20. Detection of
Concolino P; Capoluongo E
Expert Rev Mol Diagn; 2019 Sep; 19(9):795-802. PubMed ID: 31429350
[No Abstract] [Full Text] [Related]
[Next] [New Search]